First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults
Clinical trial NCT04896086 · COMPLETED
Trial details
- NCT number
- NCT04896086
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-24
- Primary completion
- 2024-01-25
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.